Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1895 (LINC01895) is a member of the **long intergenic non-coding RNA (lincRNA)** family, which are defined as RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes and are generally not translated into proteins[1][5]. LINC01895 is annotated in genomic databases and characterized by the absence of known protein-coding capacity[1]. As with other lincRNAs, its precise function is not well defined, but lincRNAs as a class are known to regulate gene expression at transcriptional or epigenetic levels, affect chromatin organization, and participate in regulatory networks[3][5]. LINC01895 does not currently have validated status as a **therapeutic target, biomarker, or disease-associated gene** based on the available search results. There are no known drug interactions, mechanisms of action, or reported disease associations specific to LINC01895. \n\nLINC01895 should be considered a non-coding RNA with **putative regulatory functions** typical of the broader long non-coding RNA family, pending further experimental characterization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1895 (LINC01895).